Back to mobile site

Lannett (LCI) to Acquire Kremers Urban Pharmaceuticals in $1.23B + Contingency Payments Deal

September 2, 2015 4:31 PM EDT Send to a Friend
Lannett (NYSE: LCI) announced that it has signed a definitive agreement to purchase Kremers Urban Pharmaceuticals Inc. (KU), the U.S ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login